CicloMed Presents New Oncology Data from Phase I Trial with Fosciclopirox at 2020 ASCO Genitourinary Cancers Symposium
13 févr. 2020 09h15 HE
|
CicloMed LLC
First-time results from recently completed fosciclopirox Phase I safety, dose tolerance, pharmacokinetics and pharmacodynamics trial in advanced solid-tumor patientsInitiation of fosciclopirox...
Streetwise Reports Publishes 'Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer Detection and Surgery'
15 janv. 2020 07h00 HE
|
Streetwise Reports Llc
SAN FRANCISCO, Jan. 15, 2020 (GLOBE NEWSWIRE) -- Imagin Medical Inc. (IME:CSE; IMEXF:OTCQB) is developing technology that can greatly improve the ability to visualize cancer during minimally...
CicloMed Expands Fosciclopirox Phase 1 Trial to Include Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients
03 déc. 2019 09h30 HE
|
CicloMed LLC
KANSAS CITY, Mo., Dec. 03, 2019 (GLOBE NEWSWIRE) -- CicloMed LLC, a biotechnology company developing novel treatments for bladder cancer, today announced the expansion of its fosciclopirox clinical...
Le 5e cancer le plus courant au Canada classé au 21e rang au niveau du financement de la recherche - Aidez-nous dès aujourd’hui et ravivez l’espoir des Canadiens touchés par le cancer de la vessie
27 août 2019 14h53 HE
|
Bladder Cancer Canada
TORONTO, 27 août 2019 (GLOBE NEWSWIRE) -- Cette année, ce sont près de 9 000 Canadiens qui recevront un diagnostic de cancer de la vessie1. Bien qu’il s’agisse du 5e cancer le plus courant au...
Fifth most common cancer now ranked 21st in terms of cancer research funding - Your time to help is NOW!
27 août 2019 14h53 HE
|
Bladder Cancer Canada
TORONTO, Aug. 27, 2019 (GLOBE NEWSWIRE) -- This year about 9,000 Canadians will be diagnosed with bladder cancer1. It’s the 5th most common cancer in Canada – yet many Canadians have never heard of...
Constellation Pharmaceuticals Presents Poster on Studies of CPI-0209 in Bladder Cancer at AACR Meeting
20 mai 2019 07h00 HE
|
Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., May 20, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today announced that Dr. Patricia Keller, Senior Scientist at Constellation...
Cancer de la vessie Canada célèbre son 10e anniversaire
10 mai 2019 08h09 HE
|
Bladder Cancer Canada
TORONTO, 10 mai 2019 (GLOBE NEWSWIRE) -- Le 11 mai, il y a de cela 10 ans, deux survivants du cancer de la vessie — David Guttman et Jack Moon — ont pris des mesures qui auront une incidence...
Bladder Cancer Canada celebrates ten years
10 mai 2019 08h09 HE
|
Bladder Cancer Canada
TORONTO, May 10, 2019 (GLOBE NEWSWIRE) -- On May 11, ten years ago, two bladder cancer survivors – David Guttman and Jack Moon – took action that would positively impact countless Canadians. Seeing...
BCAN Kicks Off Bladder Cancer Awareness Month
24 avr. 2019 12h01 HE
|
Bladder Cancer Advocacy Network (BCAN)
Bethesda, MD, April 24, 2019 (GLOBE NEWSWIRE) -- On May 1, 2019, the Bladder Cancer Advocacy Network (BCAN) begins its annual Bladder Cancer Awareness Month activities and Walks to End Bladder...
The Bladder Cancer Advocacy Network Announces The 2019 Young Investigator Awards
14 janv. 2019 07h00 HE
|
Bladder Cancer Advocacy Network (BCAN)
Bethesda, Maryland, Jan. 14, 2019 (GLOBE NEWSWIRE) -- The Bladder Cancer Advocacy Network (BCAN) is pleased to announce our 2019 Young Investigator Awards (YIA), to support the development of...